Tenon Financial LLC Makes New Investment in HCA Healthcare, Inc. (NYSE:HCA)

26 Oct 2024, 11:09 by Danessa Lincoln · The Markets Daily

Tenon Financial LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 908 shares of the company’s stock, valued at approximately $369,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. CreativeOne Wealth LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at approximately $231,000. New Mexico Educational Retirement Board grew its position in shares of HCA Healthcare by 29.9% in the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after purchasing an additional 3,200 shares during the period. Bessemer Group Inc. boosted its position in HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after acquiring an additional 2,584 shares during the last quarter. Empowered Funds LLC boosted its position in HCA Healthcare by 54.3% during the 1st quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock worth $4,639,000 after acquiring an additional 4,893 shares during the last quarter. Finally, Swedbank AB acquired a new stake in shares of HCA Healthcare in the 1st quarter valued at approximately $95,882,000. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. UBS Group increased their price objective on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Five investment analysts have rated the stock with a hold rating, twelve have given a buy rating and four have given a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $377.17.

Read Our Latest Analysis on HCA Healthcare

HCA Healthcare Stock Performance

NYSE:HCA opened at $363.75 on Friday. The stock’s 50-day simple moving average is $395.26 and its 200 day simple moving average is $352.63. HCA Healthcare, Inc. has a twelve month low of $220.55 and a twelve month high of $417.14. The firm has a market capitalization of $93.87 billion, a PE ratio of 17.08, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $4.29 earnings per share. On average, analysts anticipate that HCA Healthcare, Inc. will post 22.48 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.73%. HCA Healthcare’s dividend payout ratio is 12.39%.

Insider Activity at HCA Healthcare

In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,345 shares of company stock valued at $5,747,945 over the last 90 days. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

(Free Report)